(Q43517336)
Statements
Multicenter phase II trial to investigate safety and efficacy of gemcitabine combined with cetuximab as adjuvant therapy in pancreatic cancer (ATIP) (English)
H Fensterer
C Schade-Brittinger
H-H Müller
S Tebbe
J Fass
U Lindig
U Settmacher
W E Schmidt
A Märten
M P Ebert
M Kornmann
R Hofheinz
E Endlicher
C Brendel
P J Barth
D K Bartsch
P Michl
Arbeitsgemeinschaft Internistische Onkologie